|
Analyst Rating Change Notice
|
3
|
Resverlogix Corp.
|
Jan 09, 2017 08:45AM
|
|
New compound - ApaBearDownAzone
|
9
|
Resverlogix Corp.
|
Jun 01, 2017 03:10PM
|
|
Re: Zenith new VP
|
3
|
Zenith Epigenetics
|
Jul 29, 2017 06:48PM
|
|
Re: Value
|
2
|
Zenith Epigenetics
|
Aug 19, 2017 04:06PM
|
|
Trading volumes
|
4
|
Resverlogix Corp.
|
Sep 12, 2017 02:26PM
|
|
Re: BET inhibitor and BRD4 papers keep piling up
|
7
|
Resverlogix Corp.
|
Sep 24, 2017 04:41PM
|
|
Re: Explanation?
|
5
|
Resverlogix Corp.
|
Oct 05, 2017 07:55PM
|
|
Dr Nichols still loves Esperion
|
1
|
Resverlogix Corp.
|
Oct 11, 2017 03:20PM
|
|
Zenith new VP
|
2
|
Zenith Epigenetics
|
Dec 07, 2017 03:04PM
|
|
Beacon report spreading
|
7
|
Resverlogix Corp.
|
Dec 07, 2017 08:06PM
|
|
Competition from Constellation
|
4
|
Zenith Epigenetics
|
Dec 13, 2017 09:01AM
|
|
Re: Competition from Constellation
|
3
|
Zenith Epigenetics
|
Dec 14, 2017 11:15AM
|
|
Re: Zenith AGM - Q&A
|
4
|
Zenith Epigenetics
|
Dec 19, 2017 01:09PM
|
|
Beacon reiterates assessment
|
5
|
Resverlogix Corp.
|
Dec 20, 2017 07:38PM
|
|
Israel Patent Application
|
5
|
Resverlogix Corp.
|
Jan 10, 2018 08:49AM
|
|
Awaken Dormant DNA, Epigenetically - Article in GEN
|
6
|
Zenith Epigenetics
|
Jan 12, 2018 06:03PM
|
|
Pfizer vs J&J - Nonmetastatic prostate cancer
|
1
|
Zenith Epigenetics
|
Feb 06, 2018 09:54AM
|
|
Re: Zenith and Breast Cancer
|
6
|
Zenith Epigenetics
|
Mar 11, 2018 02:36PM
|
|
Novartis' canakinumab (Ilaris)
|
4
|
Resverlogix Corp.
|
Mar 13, 2018 01:32PM
|
|
Is CellCentric a competitor?
|
2
|
Zenith Epigenetics
|
May 15, 2018 06:27PM
|
